Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PJT Partners (PJT) Cash & Equivalents (2016 - 2025)

PJT Partners has reported Cash & Equivalents over the past 12 years, most recently at $538.9 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $538.9 million for Q4 2025, up 11.36% from a year ago — trailing twelve months through Dec 2025 was $538.9 million (up 11.36% YoY), and the annual figure for FY2025 was $538.9 million, up 11.36%.
  • Cash & Equivalents for Q4 2025 was $538.9 million at PJT Partners, up from $400.5 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for PJT hit a ceiling of $538.9 million in Q4 2025 and a floor of $75.8 million in Q1 2022.
  • Median Cash & Equivalents over the past 5 years was $181.5 million (2022), compared with a mean of $218.2 million.
  • Biggest five-year swings in Cash & Equivalents: crashed 38.87% in 2023 and later skyrocketed 169.06% in 2025.
  • PJT Partners' Cash & Equivalents stood at $200.5 million in 2021, then decreased by 13.59% to $173.2 million in 2022, then surged by 105.24% to $355.5 million in 2023, then surged by 36.1% to $483.9 million in 2024, then increased by 11.36% to $538.9 million in 2025.
  • The last three reported values for Cash & Equivalents were $538.9 million (Q4 2025), $400.5 million (Q3 2025), and $214.6 million (Q2 2025) per Business Quant data.